Jie Xiong

5PUBLICATIONS
6CO-AUTHORS
Solid tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 29, 2026
LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signaling.

|May 21, 2026
N6-methyladenosine reader IGF2BP2 in T-cell lymphoma.

|Jun 10, 2025
Baseline total lesion glycolysis identifies high-risk patients with immunosuppressive signatures in early-stage natural killer/T-cell lymphoma.

Xiao Gao, Jie Xiong, Xin-Yun Huang

|Mar 06, 2024
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma.

Jie Xiong, Shu Cheng, Xiao Gao

|Sep 02, 2023
A novel SLC1A1-RIC1 fusion sensitive to asparaginase-based therapy in natural killer/T-cell lymphoma.

Jie Xiong, Wei-Li Zhao

Pageof 1

Frequent Collaborators

4 joint publications

Wei-Li Zhao

1 joint publications

Yu-Ting Dai

1 joint publications

Hong-Mei Yi

1 joint publications

Yunqi Li